関連ニュース

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible

CVS Health Corporation stock remains fairly attractive as a growing industry leader, currently rated a soft Buy due to improved profitability and relative valuation. Recent results show revenue up 6.7

CVS Health Corporation's strong Q2 results delivered revenue and earnings beats while management raised operating cash flow guidance to $11.5 billion. Aetna turnaround and improved medical benefit rat

CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressu

Pharmacy-focused sites to open in select communities to help increase access to pharmacy care Openings are part of ongoing commitment to serve communities and meet consumers where they are WOONSOCKET

WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per s

CVS Health Corporation has outperformed peers, overcoming industry headwinds through effective management and strategic execution. CVS delivered a Q1 beat-and-raise, expects margin expansion in 2026,